High investment and staking, the asset-liability ratio is high.
Editor’s note: This article is from WeChat public account “IPO that thing” (ID :ipopress), author Paul.
It is reported that Pengai Medical will be listed on the US stock market on October 25, and the issue price is expected to be 11-13 US dollars.
The word “face value” is a vivid interpretation of people’s attention to appearance, even to the point of scoring. The attention and consumption of the value of the face has reached an unprecedented level, and the scores of the public are worth a half of the well-known tigers. The more directly generated economy is the medical beauty service market.
The medical and economic economy is in full swing. It can also be known from the primary market: the IPO of the new oxygen US stocks has been successful, and the existing Peng Ai Medical. It is reported that Pengai Medical will go to Nasdaq to market, the stock code is “AIH”. The company expects to issue 2.5 million ADSs, with an issue price of $11-13, and a corresponding fundraising range of $27.5 million to $32.5 million.
As a local chain of medical beauty, you can see the corner of the economy from Pengai Medical.
Yan value economy track, high growth revenue
Peng Ai Medical was established in 1997 and is currently positioned as a leading provider of medical beauty services in China, providing one-stop beauty services including surgical cosmetic treatments (eg eye surgery, rhinoplasty, breast augmentation and liposuction), non-surgical Beauty treatments (such as minimally invasive and energy-based treatments) and other beauty services (such as cosmetic dentistry).
After more than 20 years of development, Peng Ai Medical has 21 medical beauty centers (including 19 wholly-owned or holding centers), and its treatment centers are located in 15 cities in mainland China, Hong Kong and Singapore. According to Frost & Sullivan, from the perspective of income in 2018, Peng Ai Medical has become China’s third largest private beauty medical service provider.
Figure: Treatment Center Coverage
Source: Prospectus
According to Frost & Sullivan, the total market for beauty care services in China increased from RMB 52.1 billion in 2014 to RMB 121.7 billion in 2018, with a compound annual growth rate (CAGR) of 23.6%; it is expected that by 2023, Chinese doctors The US market will grow to RMB 360.1 billion, equivalent to a compound annual growth rate of 24.2% from 2018 to 2023.
The market size of private beauty medical service providers in China has grown at a compound annual growth rate of 25.5% from RMB 40 billion in 2014 to RMB 99.3 billion in 2018, and is expected to grow to RMB 316.6 billion in 2023. Yuan, compound annual growth rate of 26.1 percentage from 2018 to 2023.
In 2017, China was the second largest market for beauty care services by revenue. According to Frost & Sullivan, the global market for beauty care services totaled $125.8 million. As one of the market leaders in China, we believe that we have the conditions to benefit from a favorable downwind,
In the strong market growth, medical beauty, at least it seems to be a good business.
In the context of high industry growth, Peng Ai Medical also achieved high growth in revenue data.
In 2016, 2017 and 2018, Peng Ai Medical Beauty’s revenue was 585 million, 697 million and 761 million yuan, and revenue in the first half of 2019 was 391 million yuan, up 10.4% year-on-year.
The income of Pengai Medical mainly comes from the provision of medical beauty treatment. According to financial data for 2018, surgical cosmetic treatment, non-surgical cosmetic treatment, and general health care and other beauty services accounted for 41.2%, 49.1%, and 9.7% of total income, respectively.
Among them, the number of non-surgical cosmetic treatments increased from 124,116 in 2016 to 166,629 in 2017, an increase of 34.3%; and further to 235,367 in 2018, an increase of 41.3%. The number of surgical cosmetic treatments increased from 27,3,377 in 2016 to 63.553 in 2018.
